Involvement of protein kinase C and phosphatidylinositol 3-kinase pathways in the survival of B-cell chronic lymphocytic leukemia cells.

Blood
Montserrat BarragánJoan Gil

Abstract

B-cell chronic lymphocytic leukemia (B-CLL) is characterized by the accumulation of long-lived CD5(+) B lymphocytes. TPA (12-O-tetradecanoylphorbol 13- acetate) and interleukin-4 (IL-4) inhibit apoptosis of B-CLL lymphocytes ex vivo. We used specific inhibitors of protein kinase C (PKC), extracellular-regulated kinase (ERK), and phosphatidylinositol 3-kinase (PI3-kinase) to study their involvement in TPA- and IL-4-induced survival of B-CLL lymphocytes. BisI, a specific inhibitor of PKC, induced apoptosis and inhibited the antiapoptotic activity of TPA and IL-4. B-CLL cells have a basal PKC activity that was increased by TPA but not by IL-4. TPA, but not IL-4, induced ERK activation. However, the inhibition of ERK activation did not affect the viability of B-CLL lymphocytes, demonstrating that this pathway is not involved in their survival. Inhibition of PI3-kinase by LY294002 induced apoptosis of B-CLL cells and inhibited the survival effect of IL-4 and TPA. In addition, Akt, a downstream effector of PI3-kinase activity, was phosphorylated by TPA and IL-4 in B-CLL cells, though PI3-kinase had no effect on PKC-dependent phosphorylation of Akt. Furthermore, the inhibition of PKC or PI3-kinase increased dexamethasone- and fludarab...Continue Reading

References

Nov 24, 1995·Science·Z XiaM E Greenberg
Jan 1, 1993·The Journal of Experimental Medicine·M BuschleM K Brenner
Jan 1, 1994·The Journal of Experimental Medicine·A C FluckigerJ Banchereau
Apr 1, 1993·Japanese Journal of Cancer Research : Gann·H TsudaK Takatsuki
Apr 15, 1997·Proceedings of the National Academy of Sciences of the United States of America·N N AhmedP N Tsichlis
Apr 21, 1998·Critical Reviews in Oncology/hematology·J Jurlander
Jul 11, 1998·The Journal of Biological Chemistry·M F FavataJ M Trzaskos
Sep 25, 1998·Current Opinion in Hematology·T J Kipps
Nov 13, 1998·Science·M H CardoneJ C Reed
Jun 8, 1999·Annual Review of Immunology·K NelmsW E Paul
Jun 12, 1999·American Journal of Human Genetics·L R GoldinN Caporaso
Dec 2, 1999·Genes & Development·S R DattaM E Greenberg
Feb 5, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·R R FurmanE J Schattner
Mar 31, 2000·Experimental Cell Research·T G CrossJ M Lord
Mar 13, 2001·Leukemia·D M O'Gorman, T G Cotter

❮ Previous
Next ❯

Citations

Jul 22, 2005·Cancer Immunology, Immunotherapy : CII·Øystein BruserudBjørn Tore Gjertsen
Feb 16, 1991·Biochimica Et Biophysica Acta·P J CiaccioJ R Halpert
Apr 6, 1992·Biochimica Et Biophysica Acta·T YanagimotoT Kamataki
Feb 21, 1995·Biochimica Et Biophysica Acta·D StrotkampW G Hanstein
Oct 20, 2010·The Journal of Experimental Medicine·Ana V MileticRobert C Rickert
Jun 12, 2003·Current Opinion in Hematology·Amy J JohnsonJohn C Byrd
Dec 17, 2008·Hematology·Susan O'Brien
Jun 25, 2008·Blood·Janet Plate
Oct 10, 2009·Haematologica·Mercè de FriasJoan Gil
Nov 22, 2012·Mediterranean Journal of Hematology and Infectious Diseases·Dimitar G EfremovLuca Laurenti
Feb 21, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Asish K GhoshTait D Shanafelt
Dec 29, 2004·Leukemia & Lymphoma·Irene Munk Pedersen, John Reed
Apr 27, 2013·International Reviews of Immunology·Tadeusz Robak, Pawel Robak
Jan 24, 2004·Leukemia & Lymphoma·Montserrat BarragánJoan Gil
Jul 12, 2003·Leukemia & Lymphoma·Neil E Kay, Brian T Pittner
Sep 23, 2006·Expert Opinion on Investigational Drugs·Piotr Smolewski
Aug 13, 2013·Expert Opinion on Investigational Drugs·Janusz KrawczykFrancis J Giles
Aug 19, 2004·Journal of Cellular Physiology·Giovanna TabelliniAlberto M Martelli
Nov 30, 2005·The American Journal of Pathology·Paola SecchieroGiorgio Zauli

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.